Want to join the conversation?
Biopharmaceutical company $GILD said the 48-week results from Study 1089, evaluating the safety and efficacy of switching virologically suppressed HIV-1 infected adult patients from F/TDF Truvada-based regimens to F/TAF-based regimens, showed improvements in renal and bone laboratory parameters in patients receiving F/TAF-based regimens.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.